|
 |
|
|
 
|
|
Eugene Fine, M.D.
Professor of Clinical Nuclear Medicine Albert Einstein College of Medicine / Montefiore Medical Center |
|
Dr. Fine's
professional interests have centered on non-invasive measurement of physiologic
and molecular function, especially with radiotracer technology. This was applied
to the heart and to measurement of kidney function and its role and
contribution to hypertension; and more recently has focused on radiotracers for
diagnosis, monitoring, prognosis, and identification of cancers for appropriate
therapy.
Dr. Fine has most recently become interested in the effects of dietary and
nutritional manipulation, and reducing carbohydrate content, on
altering our internal metabolic environment. Carbohydrate restriction in humans
mimics many of the metabolic effects of fasting, and may be systematically
studied using appropriate in vitro, cell culture, animal models and in vivo
biochemical and radiotracer techniques. Of particular interest is the potential
for differential systemic metabolic effects on malignant compared to normal
cells.
Publications
Reduced Carbohydrates Against Resistant Growth Tumors RECHARGE is a University
affiliated, IRB approved clinical trial being conducted at the Albert Einstein
College of Medicine in New York
|
|
|
